Eco R1 Capital, LLC Ascendis Pharma A/S Transaction History

Eco R1 Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $2.29 Million - $3 Million	27,208 New	27,208 $2.81 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $38.6 Million - $47.7 Million	-360,819 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$62.15 - $129.99 $19.8 Million - $41.5 Million	-318,927 Reduced 46.92%	360,819 $42.5 Million
Q4 2018 Feb 14, 2019	SELL	$55.16 - $69.67 $22.5 Million - $28.4 Million	-407,511 Reduced 37.48%	679,746 $42.6 Million
Q3 2018 Nov 14, 2018	SELL	$63.77 - $76.28 $24 Million - $28.7 Million	-376,810 Reduced 25.74%	1,087,257 $77 Million
Q2 2018 Aug 14, 2018	SELL	$58.55 - $73.92 $21 Million - $26.5 Million	-358,508 Reduced 19.67%	1,464,067 $97.4 Million
Q1 2018 May 15, 2018	SELL	$38.98 - $68.04 $11.1 Million - $19.4 Million	-285,025 Reduced 13.52%	1,822,575 $119 Million
Q3 2017 Nov 14, 2017	BUY	$26.89 - $37.1 $56.7 Million - $78.2 Million	2,107,600	2,107,600 $76.4 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.